FDA Rejects MDMA-Assisted Therapy for PTSD
MedPage Today) — The FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD), calling for another trial to evaluate the drug’s efficacy and safety, developer Lykos Therapeutics announced on Friday. Lykos…
MedPage Today) — The FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD), calling for another trial to evaluate the drug’s efficacy and safety, developer Lykos Therapeutics announced on Friday.
Lykos…
Read More
About Author
